KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.11 $2.08 Friday, 26th Apr 2024 OCGN stock ended at $1.28. This is 8.47% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 10.08% from a day low at $1.19 to a day high of $1.31.
90 days $0.495 $2.10
52 weeks $0.345 $2.10

Historical Ocugen Inc prices

Date Open High Low Close Volume
Apr 26, 2024 $1.21 $1.31 $1.19 $1.28 5 356 396
Apr 25, 2024 $1.15 $1.25 $1.11 $1.18 6 817 066
Apr 24, 2024 $1.27 $1.29 $1.15 $1.18 7 239 297
Apr 23, 2024 $1.21 $1.31 $1.18 $1.25 6 852 888
Apr 22, 2024 $1.35 $1.36 $1.21 $1.24 7 638 040
Apr 19, 2024 $1.29 $1.37 $1.27 $1.32 6 414 525
Apr 18, 2024 $1.48 $1.53 $1.27 $1.32 8 005 753
Apr 17, 2024 $1.60 $1.64 $1.40 $1.44 7 142 900
Apr 16, 2024 $1.55 $1.60 $1.52 $1.59 2 927 017
Apr 15, 2024 $1.67 $1.69 $1.52 $1.59 6 833 267
Apr 12, 2024 $1.69 $1.75 $1.60 $1.71 7 988 859
Apr 11, 2024 $1.85 $1.86 $1.66 $1.69 6 701 458
Apr 10, 2024 $1.76 $1.82 $1.72 $1.80 5 676 565
Apr 09, 2024 $1.87 $1.92 $1.69 $1.71 10 126 751
Apr 08, 2024 $2.01 $2.08 $1.84 $1.88 19 457 866
Apr 05, 2024 $1.58 $1.91 $1.55 $1.83 20 483 895
Apr 04, 2024 $1.55 $1.67 $1.51 $1.51 8 101 321
Apr 03, 2024 $1.37 $1.60 $1.36 $1.51 9 938 663
Apr 02, 2024 $1.44 $1.45 $1.34 $1.38 9 464 758
Apr 01, 2024 $1.61 $1.61 $1.43 $1.54 8 782 120
Mar 28, 2024 $1.75 $1.76 $1.57 $1.64 9 033 335
Mar 27, 2024 $1.73 $1.85 $1.62 $1.78 10 453 798
Mar 26, 2024 $1.83 $2.00 $1.52 $1.73 27 360 951
Mar 25, 2024 $1.87 $2.10 $1.72 $1.83 43 460 018
Mar 22, 2024 $1.45 $1.71 $1.41 $1.64 31 628 225
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT